The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference32 articles.
1. Cancer statistics;Boring;CA Cancer J Clin,1993
2. Deferred treatment in localised prostate cancer;Adolfsson;Br J Urol,1992
3. Natural history of localised prostate cancer managed by conservative therapy alone;George;Lancet,1988
4. High 10 year survival rate in patients with early untreated prostate cancer;Johansson;J Am Med Assoc,1992
5. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate;Voges;Cancer,1992
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Study of Expression of P53 in Prostatic Lesions;Journal of Pharmaceutical Research International;2021-04-09
2. Prostate cancer aggressiveness and age: Impact of p53, BCL-2 and microvessel density;Journal of Investigative Medicine;2018-10-07
3. Prostate Cancer: An Update on Molecular Pathology with Clinical Implications;European Urology Supplements;2017-12
4. Molecular Updates in Prostate Cancer;Surgical Pathology Clinics;2015-12
5. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy;Urologic Oncology: Seminars and Original Investigations;2013-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3